RADIATION THERAPY ONCOLOGY GROUP
RTOG 0617/NCCTG N0628/CALGB 30609/ECOG R0617
A RANDOMIZED PHASE III COMPARISON OF STANDARD-DOSE (60 Gy) VERSUS HIGHDOSE (74 Gy) CONFORMAL RADIOTHERAPY WITH CONCURRENT AND CONSOLIDATION CARBOPLATIN/PACLITAXEL +/- CETUXIMAB (IND #103444) IN PATIENTS WITH STAGE IIIA/IIIB NON-SMALL CELL LUNG CANCER
RTOG 0617/NCCTG N0628/CALGB 30609/ECOG R0617
A RANDOMIZED PHASE III COMPARISON OF STANDARD-DOSE (60 Gy) VERSUS HIGHDOSE (74 Gy) CONFORMAL RADIOTHERAPY WITH CONCURRENT AND CONSOLIDATION CARBOPLATIN/PACLITAXEL +/- CETUXIMAB (IND #103444) IN PATIENTS WITH STAGE IIIA/IIIB NON-SMALL CELL LUNG CANCER
Protocol Participation Information
- Credentialing
- Credentialing Requirements (Contact RPC at 713-745-8989 with any questions.)
- Facility Questionnaire: Part I and Part III are required for this protocol.
- Digital Data Submission
- Digital Data Submission Procedures
- Digital Data Submission Information (DDSI) Form
- ATC Compliant Treatment Planning Systems
Please note: Participants submitting treatment planning data for this protocol using RTOG Data Exchange format should download the ITC MU Reporting Form (Excel spreadsheet), enter the MUs delivered for each beam, and submit the completed spreadsheet along with their digital data submission to the ITC. Please contact Bill Straube (314-362-9762, itc@wustl.edu) for further information. This form is not required for data submission using DICOM.
- Structure Names
- Protocol Text (http://www.rtog.org)
Back to protocols
